Eun-Kyu Koh to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Eun-Kyu Koh has written about Drug Resistance, Neoplasm.
Connection Strength
0.021
-
A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy. Cancer Chemother Pharmacol. 2012 Dec; 70(6):843-53.
Score: 0.021